Serotonin transporter availability in major depression : Single Photon Emission Tomography Studies on Drug-Naïve Depressed Subjects: Comparison with Healthy Subjects, Effect of Genotype, and Follow-up During Psychodynamic Psychotherapy
Year: 2019
Type: dissertation
Abstract: Although depression is a long-known and common disease causing serious suffering, its biological etiology is still poorly understood.We understand, as a result of pharmacological studies, the relevance of the serotonin system.Special interest has focused on the presynaptic serotonin transporter (SERT); blocking it is the most common mechanism of antidepressants.In addition to the information gathered from pharmacological research, the significance of the SERT has been evident in studies combining genetics and environmental factors.Indirect evidence has also accumulated from studies of endophenotypes mediating vulnerability to depression.Mechanisms affecting the risk of depression include the reactivity of the limbic system, and the connections of the frontal cortex and the limbic system.Studies that combine SERT genetics and brain imaging have been especially influential in this aspect.Despite our knowledge of the important role of the SERT in depression, basic research especially with drug-naïve subjects is sparse.The role of the SERT in depression is still obscure.In the first part of the thesis, SERT availability in the midbrain and medial prefrontal cortex was compared in healthy controls and patients with major depression.In the second part, the effect of allelic variation of the long promoter of the serotonin transporter (5-HTTLPR) on SERT availability was assesed in the same brain regions.The third part of the thesis concentrated on examining associations of clinical variables and neuroimaging during both psychodynamic psychotherapy and waiting for psychotherapy.The first study included 29 patients with major depression and 19 age-and sex-matched healthy control subjects.The genetic study had 23 patient participants.In the follow-up study, after the exclusion process and drop-outs, the 33 remaining patients were randomized in two groups.One started psychodynamic psychotherapy immediately and the other waited six months before starting treatment.At the end of the first year of treatment, 24 subjects remained in the study.SERT availability was imaged with Single Photon Emission Tomography (SPET) using the [123I] nor-β-CIT ligand.Psychiatric diagnoses were aided by an SCID interview.Depression symptoms were assessed with multiple scales, such as BDI, HAM-17, and MADRS.Overall psychiatric symptoms were measured with the Symptom Check List (SCL).SERT availability in the midbrain decreased in depression.Second, due to the small sample size, the preliminary finding was the effect of 5-HTTLPR on SERT availability in the prefrontal cortex.Depressed patients homozygous for the lower SERT-expressing S-allele had decreased SERT availability in the medial prefrontal cortex, compared to other patients.In the follow-up study, baseline symptom severity correlated with change in SERT availability during both psychodynamic psychotherapy and waiting for therapy.Those patients with more severe symptoms had a higher increase of SERT availability during the followup.Clinical changes and neuroimaging changes, however, had no correlation with each other.Despite the significant difference in SERT availability found between depressed patients and healthy controls, SERT imaging is unsuitable as a diagnostic procedure due to the substantial overlap of the results of depressed and healthy individuals.Symptom severity lacks correlation with SERT availability.9
Author: Joensuu, Mikko
Institution: University of Eastern Finland
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7043200675
